If it wasn't for the question of financing there wouldn't be all this speculation going on....How is the company financing current activities and how are they going to pay for everything being announced like trials for CKD and Fabry?  They sure are making the most of that $5 or so million they had left in cash at the end of January...4 months on and they're still chugging away....

How?  

Meh....we're just shareholders, owners of the company....what right do we have to know.

Short interest came out, current to May 31st...it jumped 700 to 229,700....and the share count is reported at 105,642,444 while at the end of January it was at 105,428,124....that's a difference of 214,320 shares if I punched the numbers right.